BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morris TC, Hoggart CJ, Chegou NN, Kidd M, Oni T, Goliath R, Wilkinson KA, Dockrell HM, Sichali L, Banda L, Crampin AC, French N, Walzl G, Levin M, Wilkinson RJ, Hamilton MS. Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa. Front Immunol 2021;12:639174. [PMID: 33717190 DOI: 10.3389/fimmu.2021.639174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gumbo R, Sylvester TT, Parsons SDC, Buss PE, Warren RM, van Helden PD, Miller MA, Kerr TJ. Comparison of interferon gamma release assay and CXCL9 gene expression assay for the detection of Mycobacterium bovis infection in African lions (Panthera leo). Front Cell Infect Microbiol 2022;12:989209. [DOI: 10.3389/fcimb.2022.989209] [Reference Citation Analysis]
2 Meca A, Turcu-stiolica A, Bogdan M, Subtirelu M, Cocoș R, Ungureanu BS, Mahler B, Pisoschi C. Screening performance of C-reactive protein for active pulmonary tuberculosis in HIV-positive patients: A systematic review with a meta-analysis. Front Immunol 2022;13:891201. [DOI: 10.3389/fimmu.2022.891201] [Reference Citation Analysis]
3 Garlant HN, Ellappan K, Hewitt M, Perumal P, Pekeleke S, Wand N, Southern J, Kumar SV, Belgode H, Abubakar I, Sinha S, Vasan S, Joseph NM, Kempsell KE. Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis. Front Immunol 2022;13:854327. [DOI: 10.3389/fimmu.2022.854327] [Reference Citation Analysis]
4 Gill CM, Dolan L, Piggott LM, Mclaughlin AM. New developments in tuberculosis diagnosis and treatment. Breathe 2022;18:210149. [DOI: 10.1183/20734735.0149-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jacobs R, Awoniyi DO, Baumann R, Stanley K, McAnda S, Kaempfer S, Malherbe ST, Singh M, Walzl G, Chegou NN; AE-TBC Consortium. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis. Tuberculosis (Edinb) 2022;133:102169. [PMID: 35121532 DOI: 10.1016/j.tube.2022.102169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo Y, Xue Y, Song H, Tang G, Liu W, Bai H, Yuan X, Tong S, Wang F, Cai Y, Sun Z. Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection. J Infect 2022:S0163-4453(21)00666-6. [PMID: 34995637 DOI: 10.1016/j.jinf.2021.12.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Luo Y, Xue Y, Tang G, Lin Q, Song H, Liu W, Yin B, Huang J, Wei W, Mao L, Wang F, Sun Z. Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection. Front Immunol 2021;12:761209. [PMID: 34858413 DOI: 10.3389/fimmu.2021.761209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol 2021;12:725447. [PMID: 34691031 DOI: 10.3389/fimmu.2021.725447] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Namuganga AR, Chegou NN, Mayanja-Kizza H. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis. Front Med (Lausanne) 2021;8:709793. [PMID: 34631731 DOI: 10.3389/fmed.2021.709793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Liu W, Tong S, Hou H, Huang M, Ouyang R, Wang F, Sun Z. Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection. Front Immunol 2021;12:721013. [PMID: 34512645 DOI: 10.3389/fimmu.2021.721013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]